Several studies have also investigated the relation between systemic inflammation and breast cancer survival, reporting a significant association between shorter survival and elevated concentration of circulating inflammatory biomarkers, such as serum amyloid A (SSA) and systemic c-reactive protein (CRP) and serum interleukin-6 [32,33]. The gene discussed is CRP; the disease is breast cancer.